MoneyWorks4Me

The June 2024 quarter revenue stood at Rs. 15576.10 millions, up 5.32% as compared to Rs. 14790.00 millions during the corresponding quarter last year.Profit saw a slight increase of 13.01%to Rs. 3280.10  millions from Rs. 2902.40 millions.The company reported a good operating profit of 4583.40 millions compared to 4110.00 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 15576.10 14790.00 5.32 15576.10 14790.00 5.32 58489.10 53487.30 9.35
Other Income 673.30 560.00 20.23 673.30 560.00 20.23 2482.70 1541.50 61.06
PBIDT 4583.40 4110.00 11.52 4583.40 4110.00 11.52 17013.70 13597.80 25.12
Interest 27.50 33.40 -17.66 27.50 33.40 -17.66 124.50 159.90 -22.14
PBDT 4555.90 4076.60 11.76 4555.90 4076.60 11.76 16889.20 13437.90 25.68
Depreciation 183.70 171.70 6.99 183.70 171.70 6.99 711.70 699.70 1.72
PBT 4372.20 3904.90 11.97 4372.20 3904.90 11.97 16177.50 12738.20 27.00
TAX 1092.10 1002.50 8.94 1092.10 1002.50 8.94 4165.30 3244.10 28.40
Deferred Tax -21.60 -17.60 22.73 -21.60 -17.60 22.73 10.70 -11.90 -189.92
PAT 3280.10 2902.40 13.01 3280.10 2902.40 13.01 12012.20 9494.10 26.52
Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00
PBIDTM(%) 29.43 27.79 5.89 29.43 27.79 5.89 29.09 25.42 14.42
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..